Detalhe da pesquisa
1.
Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival.
Gynecol Oncol
; 167(2): 139-145, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137845
2.
The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes.
Gynecol Oncol
; 165(3): 560-567, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606067
3.
Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer.
Gynecol Oncol
; 162(1): 65-71, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33838925
4.
Fertility preservation in rare ovarian tumors.
Int J Gynecol Cancer
; 31(3): 432-441, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649010
5.
The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance.
Gynecol Oncol
; 158(3): 653-658, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32709538
6.
Low-grade serous ovarian cancer: State of the science.
Gynecol Oncol
; 156(3): 715-725, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969252
7.
Lymphopenia and its association with survival in patients with locally advanced cervical cancer.
Gynecol Oncol
; 140(1): 76-82, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26571200
8.
Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors.
Gynecol Oncol
; 159(3): 601-603, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33019983
9.
Clinical and genomic landscape of RAS mutations in gynecologic cancers.
Clin Cancer Res
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687597
10.
Treatment of Rare Epithelial Ovarian Tumors.
Hematol Oncol Clin North Am
; 32(6): 1011-1024, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30390757